| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191971 | Annals of Allergy, Asthma & Immunology | 2011 | 8 Pages |
Abstract
This analysis supports current guideline recommendations for the use of LABAs only as add-on therapy to ICS.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
James MD, Linda MD, Ying PhD, Vijay Kumar Thygarajan PhD, David PhD, Steve MD,